Effect of Nitroglycerin Hydrogel on Repairing Critical Bone Defects
Launched by MINIA UNIVERSITY · Apr 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special gel containing nitroglycerin on healing serious bone injuries that don't heal on their own, known as critical-sized bone defects. These types of injuries can occur in conditions like bone loss or fractures and often require additional medical intervention. The researchers are exploring how this gel can help improve bone formation by using nitroglycerin, which has been shown to enhance bone growth by promoting the activity of bone-building cells.
To participate in this trial, candidates must be adult animals aged between 3 to 7 months and weigh between 250 to 350 grams. The study is not yet recruiting participants, but once it begins, those eligible can expect to receive the nitroglycerin gel applied to their bone injuries and be closely monitored for improvements in healing. This research could potentially lead to better treatments for significant bone injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All animals were adult with an age ranging between 3 to 7 months and a weight ranging between 250 and 350 g
- Exclusion Criteria:
- • other than inclusion
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Cairo Egypt, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported